Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brontictuzumab (OMP 52M51), a monoclonal antibody (MAb), selectively targets and binds to the negative regulatory region of Notch1, inhibiting its signaling. This action inhibits tumor cell proliferation, rendering Brontictuzumab a potential therapeutic agent for leukemia and lymphoma research [1] [2] [3].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Brontictuzumab (OMP 52M51), a monoclonal antibody (MAb), selectively targets and binds to the negative regulatory region of Notch1, inhibiting its signaling. This action inhibits tumor cell proliferation, rendering Brontictuzumab a potential therapeutic agent for leukemia and lymphoma research [1] [2] [3]. |
Molecular Weight | N/A |
CAS No. | 1447814-75-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brontictuzumab 1447814-75-6 inhibitor inhibit